These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36199697)

  • 1. For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.
    Rogers JM; Smith KE; Schriefer D; Epstein DH
    Subst Abuse; 2022; 16():11782218221123977. PubMed ID: 36199697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
    Smith KE; Dunn KE; Grundmann O; Garcia-Romeu A; Rogers JM; Swogger MT; Epstein DH
    Exp Clin Psychopharmacol; 2022 Dec; 30(6):983-996. PubMed ID: 34735202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

  • 4. Current and Future Potential Impact of COVID-19 on Kratom (
    Singh D; Brown PN; Cinosi E; Corazza O; Henningfield JE; Garcia-Romeu A; McCurdy CR; McMahon LR; Prozialeck WC; Smith KE; Swogger MT; Veltri C; Walsh Z; Grundmann O
    Front Psychiatry; 2020; 11():574483. PubMed ID: 33324252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom use as more than a "self-treatment".
    Smith KE; Dunn KE; Rogers JM; Grundmann O; McCurdy CR; Garcia-Romeu A; Schriefer D; Swogger MT; Epstein DH
    Am J Drug Alcohol Abuse; 2022 Nov; 48(6):684-694. PubMed ID: 35767669
    [No Abstract]   [Full Text] [Related]  

  • 6. Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults.
    Smith KE; Panlilio LV; Feldman JD; Grundmann O; Dunn KE; McCurdy CR; Garcia-Romeu A; Epstein DH
    JAMA Netw Open; 2024 Jan; 7(1):e2353401. PubMed ID: 38277146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kratom Retail Availability in Fort Worth, Texas.
    LoParco CR; Yockey RA; Sekhon VK; Olsson S; Galindo R; Balasundaram R; Agwuncha T; Rossheim ME
    J Psychoactive Drugs; 2024; 56(1):8-13. PubMed ID: 36841785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample.
    Smith KE; Rogers JM; Strickland JC
    J Psychoactive Drugs; 2022; 54(5):429-439. PubMed ID: 34842079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH).
    Falise AM; Hoeflich CC; Nutley SK; Lopez-Quintero C; Striley CW
    Am J Addict; 2023 Jan; 32(1):76-80. PubMed ID: 36222599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States.
    Prozialeck WC; Lamar PC; Krupp M; Moon M; Phelps LE; Grundmann O
    Front Pharmacol; 2021; 12():729220. PubMed ID: 34512353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program.
    Smith KE; Lawson T
    Drug Alcohol Depend; 2017 Nov; 180():340-348. PubMed ID: 28950240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults.
    Smith KE; Dunn KE; Rogers JM; Garcia-Romeu A; Strickland JC; Epstein DH
    J Addict Med; 2022 Nov-Dec 01; 16(6):666-670. PubMed ID: 35220331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.
    Gutridge AM; Robins MT; Cassell RJ; Uprety R; Mores KL; Ko MJ; Pasternak GW; Majumdar S; van Rijn RM
    Br J Pharmacol; 2020 Apr; 177(7):1497-1513. PubMed ID: 31705528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States.
    Lake S; Assaf RD; Gorbach PM; Cooper ZD
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):482-490. PubMed ID: 35467920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).
    Boyer EW; Babu KM; Adkins JE; McCurdy CR; Halpern JH
    Addiction; 2008 Jun; 103(6):1048-50. PubMed ID: 18482427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data.
    Grundmann O; Veltri CA; Morcos D; Knightes Iii D; Smith KE; Rogers JM
    Subst Abus; 2022; 43(1):865-877. PubMed ID: 35179453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.